Vertex Pharmaceuticals Just Made a Major Move: Is the Stock a Buy?
Vertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
Plan zero based budgets for families to create a shared financial vision, allocate funds, and pursue common goals together.
19,937 articlesVertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
SpaceX held firm through a choppy month, outperforming peers in the space stock group. The market’s rotation favored ...
Synopsys stock faces near-term headwinds despite rising revenue, as margins and debt weigh on the long-term outlook. ...
XRP ETFs posted their first weekly red bar after months of inflows, while Bitcoin and Ethereum ETFs logged solid gain...
Five of america's biggest banks kick off a pivotal earnings week. Here's what to watch as each reports and how the re...
Banks and mortgage lenders are accelerating the use of predictive analytics real estate to forecast seller motion and...
A famous AI investor argues the economics of AI deployment could shift cash flow toward infrastructure vendors like N...
Dell Technologies has surged on AI demand, pushing year-to-date gains toward 230% as investors bet the hardware giant...
What if you had started January with a tech-focused Vanguard ETF? This deep dive explains why a January move into thi...
Mitsubishi closed a $7.5 billion acquisition of Aethon Energy's U.S. gas assets, creating Adamas Energy in Dallas. Th...
Goldman Sachs foresees a trillion-dollar space economy within the next two decades, underpinned by commercial growth ...
Hyperion, a public hyperliquid treasury firm, announces a 500,000 HYPE token deal with Skew under a HAUS agreement, e...